What ended the ByHeart baby‑formula botulism outbreak?

Health authorities declare outbreak over while probe continues

Federal public‑health officials in the United States have declared the botulism outbreak associated with ByHeart baby formula over, even as investigations into the root cause continue. The Centers for Disease Control and Prevention led the response, working with other agencies to identify cases, coordinate recalls, and trace the implicated products.

Investigators focused on identifying contaminated batches, mapping distribution, and testing remaining product samples and production environments for the botulinum toxin and possible sources of contamination. Public‑health actions, including market withdrawals and guidance to clinicians and parents, helped halt new reported cases and break the chain of exposure.

Ongoing work and consequences:

• Laboratory and facility investigations continue to determine how contamination occurred, whether it was a one‑off manufacturing lapse, a supply‑chain issue, or related to an ingredient.
• Regulators and the company are examining corrective steps; those could include changes to sanitation, process controls, supplier vetting, or product testing protocols.
• Families affected by the outbreak and clinicians involved in diagnosis and treatment remain a priority for follow‑up and support.

It’s still unclear what specific manufacturing or supply‑chain failure led to the contamination, and whether the probe will prompt new industry‑wide rules for infant‑formula production. The declaration that the outbreak is over signals that active transmission has stopped, but federal investigators will keep working to identify causes so regulators can recommend measures to prevent similar incidents in the future.